Amphipols

US12534550B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12534550-B2
Application numberUS-201917298328-A
CountryUS
Kind codeB2
Filing dateDec 3, 2019
Priority dateDec 3, 2018
Publication dateJan 27, 2026
Grant dateJan 27, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to polymeric compounds of formula I which allow the solubilization and/or stabilization of membrane proteins, it relates in particular to the complexes they form with membrane proteins and the method of solubilizing and/or stabilizing membrane proteins comprising the use of these compounds.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A water-soluble membrane protein-amphiphilic vinyl polymer complex comprising the amphiphilic vinyl polymer of formula I: wherein: M + is an alkali metal, R 1 , R 4 , R 5 , R 8 are each independently a hydrogen atom or a methyl radical, R 2 , R 6 , R 9 are each independently a group selected from a hydrogen atom, linear (C1-C8) alkyls, and branched (C3-C8) alkyls, R 10 is a group selected from linear (C1-C5) alkyls and branched (C3-C5) alkyls, R 3 and R 7 are each independently a group selected from the group consisting of: hydrogen, with X then being a single bond, linear or branched alkyls of at least 6 carbon atoms, linear or branched alkenyls of at least 6 carbon atoms, linear or branched alkynyls of at least 6 carbon atoms, with X then being a single bond, (C3-C10) cycloalkyls or (C3-C10) (hetero) cycloalkyls, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, and linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (3-C8) alkenylenes, linear (C2-C8) alkynylenes and branched (C3-C8) alkynylenes, (C3-C10) cycloalkenyls or (C3-C10) (hetero) cycloalkenyls, poly or monounsaturated, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (C2-C8) alkenylenes, linear (C2-C8) alkynylenes and branched (C2-C8) alkynylenes, poly or monounsaturated polycycles, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, and linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes or branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (C2-C8) alkenylenes, linear (C2-C8) alkynylenes and branched (C3-C8) alkynylenes, and phenyl, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, and linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (C3-C8) alkenylenes, linear (C2-C8) alkynylenes, and branched (C3-C8) alkynylenes, with w, x, y, z corresponding to the respective percentages of the units, with x being between 20 and 90%, with y being between 0 and 80%, with w being between 0 and 80%, and with z being between 0 and 60%, provided that w+x+y+z=100%, and that y or w is at least 10%, provided that when one of the groups R 3 or R 7 is a linear or branched alkyl of at least 6 carbon atoms, a linear or branched alkenyl of at least 6 carbon atoms, a linear or branched alkynyl of at least 6 carbon atoms, or a hydrogen atom, with X being a single bond, then w and y are different from 0 and the other group R 3 or R 7 is selected from the group consisting of: C3-C10) cycloalkyls or (C3-C10) (hetero) cycloalkyls, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, and linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (C3-C8) alkenylenes, linear (C2-C8) alkenylenes and branched (C3-C8) alkynylenes, (C3-C10) cycloalkenyls or (C3-C10) (hetero) cycloalkenyls, poly or monounsaturated, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, and linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes or branched (C3-C8) alkenylenes, linear (C2-C8) alkynylenes, and branched (C3-C8) alkynylenes, poly or monounsaturated polycycles, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, and linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (C3-C8) alkenylenes, linear (C2-C8) alkynylenes, and branched (C3-C8) alkynylenes, and phenyl, unsubstituted or substituted by one or more radicals selected from linear, cyclic or branched (C1-C8) alkyls, linear or branched (C2-C8) alkenyls, and linear or branched (C2-C8) alkynyls, with X then being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (C3-C8) alkenylenes, linear (C2-C8) alkynylenes, and branched (C3-C8) alkynylenes. 2 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein in the amphiphilic vinyl polymer of formula I, M + is Na + . 3 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein in the amphiphilic vinyl polymer of formula I, at least one of w or y is greater than or equal to 25% and less than or equal to 80%. 4 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein in the amphiphilic vinyl polymer of formula I, R 10 is an isopropyl group. 5 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein in the amphiphilic vinyl polymer of formula I, x is at least 20% and less than or equal to 75%. 6 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein in the amphiphilic vinyl polymer of formula I, at least one of w or y is between 25% and 50%, and z is between 0% and 40%. 7 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein in the amphiphilic vinyl polymer of formula I: at least one of R 3 or R 7 is (C 6 -C 8 ) cycloalkyls, or at least one of R 3 or R 7 is phenyl, with X being selected from a single bond, linear (C2-C8) alkylenes, branched (C3-C8) alkylenes, linear (C2-C8) alkenylenes, branched (C3-C8) alkenylenes, linear (C2-C8) alkynylenes, and branched (C3-C8) alkynylenes. 8 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein in the amphiphilic vinyl polymer of formula I: each of R 1 , R 2 , R 4 , R 5 , R 6 , R 8 , and R 9 , is a hydrogen atom, at least one of R 3 or R 7 is (C 6 -C 8 ) cycloalkyl, and X is a single bond, R 10 is an isopropyl group, x is equal to 35% or 50%, y is greater than or equal to 25%, w is equal to 0%, or 25%, and z is equal to 0%, 15% or 40%, provided that w+x+y+z=100%. 9 . The water-soluble membrane protein-amphiphilic vinyl polymer complex according to claim 1 , wherein the amphiphilic vinyl polymer is selected from: 10 . The water-soluble membrane protein-amphiphil

Assignees

Inventors

Classifications

  • Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof · CPC title

  • General methods of protein analysis not limited to specific proteins or families of proteins · CPC title

  • C08F20/56Primary

    Acrylamide; Methacrylamide · CPC title

  • Preparation of metal salts or ammonium salts · CPC title

  • C08F8/32Primary

    by reaction with amines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12534550B2 cover?
The invention relates to polymeric compounds of formula I which allow the solubilization and/or stabilization of membrane proteins, it relates in particular to the complexes they form with membrane proteins and the method of solubilizing and/or stabilizing membrane proteins comprising the use of these compounds.
Who is the assignee on this patent?
Centre Nat Rech Scient, Univ Paris
What technology area does this patent fall under?
Primary CPC classification C08F20/56. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).